Gilead Sciences — Full Portfolio
5 tracked investments · listed companies and verified rows first
Tizona Therapeutics is a biotechnology company developing first-in-class immuno-oncology therapeutics, including its lead clinical-stage asset TTX-080, aimed at changing cancer progression and relapse.
AI & Machine LearningBiotechHealthtech
Vijay K. Kuchroo(Scientific Co-Founder & Advisory Board Member)Drew Pardoll(Scientific Co-Founder & Advisory Board Member)Dario Vignali(Scientific Co-Founder & Advisory Board Member)Jedd Wolchok(Scientific Co-Founder & Advisory Board Member)Christine O'Brien(Chief Executive Officer & Board Member)inCourtney Beers(Chief Scientific Officer)
Co-investorsCanaan PartnersMPM BioImpactAbingworthAstellas Venture Management LLCLightstone Ventures
Curebase provides a software platform for clinical trial management, serving contract research coordinators and trial sites.
AI & Machine LearningBiotechDigital HealthHealthtechSaaSFort Lauderdale, US
Storm Stillman(Chief Executive Officer)inTom Lemberg(Founder)in
Co-investorsAcrew CapitalBold Capital PartnersBreyer CapitalFuture Planet CapitalNotable CapitalXfund+6 more
BiotechWatertown, US
Carlo Giovanni Traverso(Director)Amy W. Schulman(Executive Officer, Director)inRobert S. Langer(Director)
BoardZafi Avnur(Director)Edmund Harrigan(Director)Catherine Reynolds(Director)
Co-investorsBill & Melinda Gates FoundationInvusKendall Capital PartnersPolaris Partners
Tentarix Biotherapeutics develops multifunctional biologics to modernize healthcare standards through precision medicine.
BiotechDeep TechHealthtechMedical Devices
BoardSrini Akkaraju(Director, Founder)Paul Kang(Director, Founder)
Co-investorsVersant VenturesSamsara BioCapital
BiotechPhiladelphia, US
Anne Chew(Director and President)
BoardKevin Mahoney(Director)
Co-investorsAndreessen HorowitzKleiner PerkinsLAVLilly Asia VenturesMilitia Hill Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.